| Title: | Lipotoxicity in a vicious cycle of pancreatic beta cell exhaustion |
|---|
| Authors: | ID Grubelnik, Vladimir (Author)
ID Zmazek, Jan (Author)
ID Završnik, Matej (Author)
ID Marhl, Marko (Author) |
|---|
| Files: |  https://www.mdpi.com/2227-9059/10/7/1627
 RAZ_Grubelnik_Vladimir_2022.pdf (2,47 MB)
MD5: 2D5204D7C3039216BAE449BF9E220331
|
|---|
| Language: | English |
|---|
| Work type: | Article |
|---|
| Typology: | 1.01 - Original Scientific Article |
|---|
| Organization: | FNM - Faculty of Natural Sciences and Mathematics
PEF - Faculty of Education
|
|---|
| Abstract: | Hyperlipidemia is a common metabolic disorder in modern society and may precede hyperglycemia and diabetes by several years. Exactly how disorders of lipid and glucose metabolism are related is still a mystery in many respects. We analyze the effects of hyperlipidemia, particularly free fatty acids, on pancreatic beta cells and insulin secretion. We have developed a computational model to quantitatively estimate the effects of specific metabolic pathways on insulin secretion and to assess the effects of short- and long-term exposure of beta cells to elevated concentrations of free fatty acids. We show that the major trigger for insulin secretion is the anaplerotic pathway via the phosphoenolpyruvate cycle, which is affected by free fatty acids via uncoupling protein 2 and proton leak and is particularly destructive in long-term chronic exposure to free fatty acids, leading to increased insulin secretion at low blood glucose and inadequate insulin secretion at high blood glucose. This results in beta cells remaining highly active in the “resting” state at low glucose and being unable to respond to anaplerotic signals at high pyruvate levels, as is the case with high blood glucose. The observed fatty-acid-induced disruption of anaplerotic pathways makes sense in the context of the physiological role of insulin as one of the major anabolic hormones. |
|---|
| Keywords: | diabetes, insulin secretion, lipids, PEP cycle, uncoupling proteins, mitochondrial dysfunction |
|---|
| Publication status: | Published |
|---|
| Publication version: | Version of Record |
|---|
| Submitted for review: | 09.05.2022 |
|---|
| Article acceptance date: | 05.07.2022 |
|---|
| Publication date: | 07.07.2022 |
|---|
| Publisher: | MDPI |
|---|
| Year of publishing: | 2022 |
|---|
| Number of pages: | str. 1-16 |
|---|
| Numbering: | Vol. 10, iss. 7 |
|---|
| PID: | 20.500.12556/DKUM-88676  |
|---|
| UDC: | 577.35:616.151 |
|---|
| ISSN on article: | 2227-9059 |
|---|
| COBISS.SI-ID: | 114930947 |
|---|
| DOI: | 10.3390/biomedicines10071627 |
|---|
| Publication date in DKUM: | 20.05.2024 |
|---|
| Views: | 303 |
|---|
| Downloads: | 22 |
|---|
| Metadata: |    |
|---|
| Categories: | Misc.
|
|---|
|
:
|
Copy citation |
|---|
| | | | Average score: | (0 votes) |
|---|
| Your score: | Voting is allowed only for logged in users. |
|---|
| Share: |  |
|---|
Hover the mouse pointer over a document title to show the abstract or click
on the title to get all document metadata. |
